-- 
Itamar Medical Gains Most in 4 Months on Chinese Approval

-- B y   R o n i t   G o o d m a n
-- 
2011-03-27T14:59:16Z

-- http://www.bloomberg.com/news/2011-03-27/itamar-medical-advances-most-in-five-months-on-chinese-approval.html
Itamar Medical Ltd. (ITMR)  rose the most
in almost four months after the maker of medical diagnostic
equipment said two of its products were approved for
distribution in China.  The shares gained 5.6 percent, the biggest increase since
Dec. 7, to 2.08 shekels at the 4:30 p.m. close in  Tel Aviv .  WatchPAT, a device for diagnosing sleep apnea, and the
companyâ€™s non-invasive cardiovascular device EndoPAT can now be
sold in the Asian country.  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  